CTT Pharmaceutical Holdings, Inc. (CTTH)
0.055
0.00 (0.00%)
USD |
OTCM |
Oct 22, 16:00
CTT Pharmaceutical Holdings Shareholders Equity (Quarterly) : 0.026M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.026M |
| March 31, 2026 | 0.0413M |
| December 31, 2025 | 0.0552M |
| September 30, 2025 | 0.0818M |
| June 30, 2025 | 0.0821M |
| March 31, 2025 | 0.0894M |
| December 31, 2024 | 0.0322M |
| September 30, 2024 | -0.0428M |
| June 30, 2024 | -0.0313M |
| March 31, 2024 | -0.0217M |
| December 31, 2023 | 0.06M |
| September 30, 2023 | -0.0193M |
| June 30, 2023 | -0.0184M |
| March 31, 2023 | -0.0096M |
| December 31, 2022 | 0.0892M |
| September 30, 2022 | 0.0224M |
| June 30, 2022 | -0.0028M |
| March 31, 2022 | -0.0003M |
| December 31, 2021 | 0.0053M |
| September 30, 2021 | -0.3432M |
| June 30, 2021 | -0.4438M |
| March 31, 2021 | |
| December 31, 2020 | -0.2868M |
| September 30, 2020 | -0.2246M |
| June 30, 2020 | -0.1164M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0144M |
| December 31, 2019 | 0.1228M |
| September 30, 2019 | 0.2435M |
| June 30, 2019 | 0.3099M |
| March 31, 2019 | 0.3777M |
| December 31, 2018 | 0.5001M |
| September 30, 2018 | 0.6227M |
| June 30, 2018 | 0.6594M |
| March 31, 2018 | -0.1269M |
| December 31, 2017 | -0.0896M |
| September 30, 2017 | -0.023M |
| June 30, 2017 | 0.026M |
| March 31, 2017 | 0.0631M |
| December 31, 2016 | -0.1059M |
| September 30, 2016 | -0.3188M |
| June 30, 2016 | -0.182M |
| March 31, 2016 | 0.0701M |
| December 31, 2015 | 0.3351M |
| September 30, 2015 | 0.7381M |
| June 30, 2015 | 0.9869M |
| March 31, 2015 | 0.3009M |
| December 31, 2014 | 0.5866M |
| September 30, 2014 | 0.0061M |
| June 30, 2014 | 0.0856M |
| March 31, 2014 | -0.2626M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 81.53B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0674M |
| Total Liabilities (Quarterly) | 0.0414M |
| Debt to Equity Ratio | 0.7462 |
| Net Debt Paydown Yield | -0.01% |